| Literature DB >> 16216653 |
Edward L Mazuchowski1, Patricia A Meier.
Abstract
Deaths due to infectious diseases are common worldwide. The autopsy, although less frequently performed than previously, is important to our understanding of disease pathogenesis. The autopsy also provides critical information regarding potential disease outbreaks. To optimize the benefits of an autopsy, the pathologist should approach the autopsy with a well-constructed differential diagnosis that provides the framework for appropriate selection of diagnostic specimens and tests. Standard microbiologic cultures, although necessary and important, are often insufficient and must be supplemented by newer molecular methodologies.Entities:
Mesh:
Year: 2005 PMID: 16216653 PMCID: PMC7119072 DOI: 10.1016/j.arcmed.2005.04.006
Source DB: PubMed Journal: Arch Med Res ISSN: 0188-4409 Impact factor: 2.235
List of infectious agents that can be identified on formalin-fixed, paraffin-embedded tissue using commercially available antibodies and/or antisera
| Virus | Bacteria | Fungi, protozoa and parasites |
|---|---|---|
| Adenovirus | ||
| Coronavirus | ||
| Cytomegalovirus | ||
| Hantavirus | ||
| Hepatitis A | ||
| Hepatitis B | ||
| Hepatitis C | ||
| Herpes Simplex Virus | ||
| HIV-1 | ||
| HIV-2 | ||
| JC virus | ||
| Parvovirus | ||
| Picornavirus | ||
| RSV | ||
| Varicella-Zoster virus |
Infectious agents that have been designated as potential biologic terrorism agents by the CDC.
Biosafety levels
| BSL-1 | Infectious agents not known to consistently cause disease in healthy adults |
| BSL-2 | Infectious agents known to cause human disease via auto-inoculation, ingestion and mucous membrane exposure |
| BSL-3 | Indigenous or exotic agents with potential for aerosol transmission; disease may have serious or lethal consequences |
| BSL-4 | Dangerous or exotic agents that pose a high risk of life-threatening disease and related agents with unknown risk of transmission |
Categorization of potential bioterrorism agents/diseases
| Category A (definition below) |
| Anthrax ( |
| Botulism ( |
| Plague ( |
| Smallpox ( |
| Tularemia ( |
| Viral hemorrhagic fevers |
| Category B (definition below) |
| Brucellosis ( |
| Epsilon toxin of |
| Food safety threats (e.g., |
| Glanders ( |
| Melioidosis ( |
| Psittacosis ( |
| Q fever ( |
| Ricin toxin from |
| Staphylococcal enterotoxin B |
| Typhus fever ( |
| Viral encephalitis |
| Water safety threats (e.g., |
| Category C (definition below) |
| Emerging infectious diseases such as Nipah virus and Hantavirus |
| Category A Diseases/Agents: High priority agents include organisms that pose a risk to national security because they can: |
| Easily be disseminated or transmitted from person to person |
| Result in high mortality rates and have the potential for major public health impact |
| Possibly cause public panic and social disruption |
| Require special action for public health preparedness |
| Category B Diseases/Agents: Second highest priority agents include those that: |
| Are moderately easy to disseminate |
| Result in moderate morbidity rates and low mortality rates |
| Require specific enhancements of CDC's diagnostic capacity and enhanced disease surveillance |
| Category C Diseases/Agents: Third highest priority agents include emerging pathogens that could be engineered for mass dissemination in the future because of: |
| Availability |
| Ease of production and dissemination |
| Potential for high morbidity and mortality rates and major health impact |
Recommended diagnostic specimens and tests for selected biological agents
| Agent | Syndrome | Diagnostic specimens | Diagnostic tests |
|---|---|---|---|
| Cutaneous | Skin at center and periphery of eschar; pleural fluid cell block, pleural tissue, mediastinal lymph node | H&E | |
| Gastrointestinal | Gram | ||
| Inhalational | Silver stain | ||
| IHC | |||
| Bubonic | Histologic sampling of multiple organs; hemorrhagic lymph nodes; lungs | H&E | |
| Pneumonic | Gram | ||
| Septicemic | Silver stain | ||
| Giemsa | |||
| IHC | |||
| DFA | |||
| Ulceroglandular | Histologic sampling of multiple organs; necrotic lymph nodes should be sampled; culture potential portal of entry (skin, throat, conjunctiva) | IHC | |
| Oculoglandular | DFA of formalin-fixed tissue | ||
| Glandular | |||
| Pharyngeal | |||
| Typhoidal | |||
| Pneumonia | |||
| Descending paralysis | Tissue for anaerobic cultures from suspected entry sites (wound, GI, respiratory) intestinal contents | Microbiologic culture | |
| Botulinum toxin mouse bioassay | |||
| Variola virus | Smallpox | Fluid from vesicle for EM | EM |
| IHC | |||
| Multiple viruses, including Ebola, Marburg, Flaviridae | Viral hemorrhagic fevers | Histologic sampling of multiple organs; serum; skin samples | PCR |
| IH | |||
| EM |
Data from MMWR 2004 (61).